Sonoma Pharma Soars After Disinfectant Allowed to Carry COVID-19 Label in Australia

Sonoma Pharmaceuticals reports jump in Q1 revenue, profit

“We have been fighting global pandemics for nearly 20 years with our safe and non-toxic Microcyn based disinfectant and we are very pleased with the test results and subsequent approval of the SARS-CoV-2 (COVID-19) label claim for our Nanocyn disinfectant in Australia,”

MicroSafe Chief Executive Safa Qadumi
  • Shares of Sonoma Pharmaceuticals Inc. (NASDAQ: SNOA) nearly tripled on heavy volume in premarket trading Friday, after the California-based producer of hypochlorous acid products and partner Dubai-based MicroSafe Group said their Nanocyn disinfectant and sanitizer was entered into the Australian Register of Therapeutic Goods for use against the SARS-CoV-2 virus.
  • Trading volume soared also to over 2 million shares, compared with the full day average of about 43,000 shares.
  • Nanocyn is manufactured using Sonoma’s Microcyn technology.

Source: MarketWatch

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s